Drugmakers that aren’t ready when financial opportunity knocks could get caught flat-footed in a competitive market.
As M&A rebounds, here’s how pharmas can prepare to seal a deal
As M&A rebounds, here’s how pharmas can prepare to seal a deal is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: PharmaVoice